Population attributable risks of esophageal and gastric cancers

被引:521
|
作者
Engel, LS
Chow, WH
Vaughan, TL
Gammon, MD
Risch, HA
Stanford, JL
Schoenberg, JB
Mayne, ST
Dubrow, R
Rotterdam, H
West, AB
Blaser, M
Blot, WJ
Gail, MH
Fraumeni, JF
机构
[1] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
[2] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98195 USA
[3] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[4] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA
[5] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
[6] New Jersey Dept Hlth & Senior Serv, Canc Epidemiol Serv, Trenton, NJ USA
[7] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA
[8] NYU, Dept Pathol, New York, NY 10016 USA
[9] NYU, Sch Med, Dept Med, New York, NY USA
[10] Int Epidemiol Inst, Rockville, MD USA
关键词
D O I
10.1093/jnci/djg047
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Several risk factors have been identified for esophageal adenocarcinoma, gastric cardia adenocarcinoma, esophageal squamous cell carcinoma, and noncardia gastric adenocarcinoma, but no study has comprehensively examined their contributions to the cancer burden in the general population. Herein, we estimate the population attributable risks (PARs) for various risk factors observed in a multicenter population-based case-control study. Methods: We calculated PARs by using 293 patients with esophageal adenocarcinoma, 261 with gastric cardia adenocarcinoma, 221 with esophageal squamous cell carcinoma, 368 with noncardia gastric adenocarcinoma, and 695 control subjects. We included smoking for all four tumor types and Helicobacter pylori infection for noncardia gastric adenocarcinoma as established causal risk factors as well as several other factors for which causality is under evaluation. Results: Ever smoking, body mass index above the lowest quartile, history of gastroesophageal reflux, and low fruit and vegetable consumption accounted for 39.7% (95% confidence interval [CI] = 25.6% to 55.8%),41.1% (95% CI = 23.8% to 60.9%), 29.7% (95% CI = 19.5% to 42.3%), and 15.3% (95% CI = 5.8% to 34.6%) of esophageal adenocarcinomas, respectively, with a combined PAR of 78.7% (95% CI = 66.5% to 87.3%). Ever smoking and body mass index above the lowest quartile were responsible for 45.2% (95% CI = 31.3% to 59.9%) and 19.2% (95% CI = 4.9% to 52.0%) of gastric cardia adenocarcinomas, respectively, with a combined PAR of 56.2% (95% CI = 38.1% to 72.8%). Ever smoking, alcohol consumption, and low fruit and vegetable consumption accounted for 56.9% (95% Cl = 36.6% to 75.1%), 72.4% (95% CI = 53.3% to 85.8%), and 28.7% (95% CI = 11.1% to 56.5%) of esophageal squamous cell carcinomas, respectively, with a combined PAR of 89.4% (95% CI = 79.1% to 95.0%). Ever smoking, history of gastric ulcers, nitrite intake above the lowest quartile, and H. pylori infection were responsible for 18.3% (95% CI = 6.5% to 41.8%), 9.7% (95% CI = 5.4% to 16.8%), 40.7% (95% CI = 23.4% to 60.7%), and 10.4% (95% CI = 0.3% to 79.6%) of noncardia gastric adenocrcinomas, respectively, with a combined PAR of 59.0% (95% CI = 16.2% to 91.4%). Conclusion: In this population, a few known risk factors account for a majority of esophageal and gastric cancers. These results suggest that the incidence of these cancers may be decreased by reducing the prevalence of smoking, gastroesophageal reflux, and being overweight and by increasing the consumption of fruits and vegetables.
引用
收藏
页码:1404 / 1413
页数:10
相关论文
共 50 条
  • [21] What’s New in Gastric and Esophageal Cancers
    Kenneth Tanabe
    Annals of Surgical Oncology, 2016, 23 : 3773 - 3773
  • [22] DOUBLE ESOPHAGEAL OF ESOPHAGO-GASTRIC CANCERS
    EDELMANN, G
    LANGRAND, L
    ANNALES DE CHIRURGIE, 1973, 27 (03): : 254 - 256
  • [23] The Molecular Biologic Basis of Esophageal and Gastric Cancers
    Pennathur, Arjun
    Godfrey, Tony E.
    Luketich, James D.
    SURGICAL CLINICS OF NORTH AMERICA, 2019, 99 (03) : 403 - +
  • [24] Simultaneous Resection of Synchronous Esophageal and Gastric Cancers
    Park, Byungjoon
    Kim, Hong Kwan
    Choi, Yong Soo
    Kim, Jhingook
    Zo, Jae Il
    Shim, Young Mog
    THORACIC AND CARDIOVASCULAR SURGEON, 2016, 64 (07): : 611 - 618
  • [25] ABO genotypes and the risk of esophageal and gastric cancers
    Chen, Yingxi
    Hu, Nan
    Liao, Linda
    Yu, Kai
    Shu, Xiao-Ou
    Zheng, Wei
    Yuan, Jian-Min
    Koh, Woon-Puay
    Qiao, You-Lin
    Fan, Jin-Hu
    Dawsey, Sanford M.
    Freedman, Neal D.
    Taylor, Philip R.
    Goldstein, Alisa M.
    Abnet, Christian C.
    BMC CANCER, 2021, 21 (01)
  • [26] ABO genotypes and the risk of esophageal and gastric cancers
    Yingxi Chen
    Nan Hu
    Linda Liao
    Kai Yu
    Xiao-Ou Shu
    Wei Zheng
    Jian-Min Yuan
    Woon-Puay Koh
    You-Lin Qiao
    Jin-Hu Fan
    Sanford M. Dawsey
    Neal D. Freedman
    Philip R. Taylor
    Alisa M. Goldstein
    Christian C. Abnet
    BMC Cancer, 21
  • [27] The Relationship Between Gastric and Esophageal Cancers in Italy
    Crocetti, Emanuele
    Mancini, Silvia
    Ravaioli, Alessandra
    Giuliani, Orietta
    Bucchi, Lauro
    Falcini, Fabio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (08): : 1201 - 1202
  • [28] Updates in Translational Science for Esophageal and Gastric Cancers
    Hompe, Eliza D.
    Sachdeva, Uma M.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 33 (03) : 571 - 581
  • [29] What's New in Gastric and Esophageal Cancers
    Tanabe, Kenneth
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (12) : 3773 - 3773
  • [30] Muscle Attenuation and Sarcopenia in Gastric and Esophageal Cancers
    Geddes, K.
    Rouse, H.
    McLachlan, S. A.
    Sundararajan, V.
    Moore, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 46 - 47